comparemela.com

Latest Breaking News On - Glenmark pharmaceuticals on - Page 3 : comparemela.com

Glenmark Pharma launches triple-combination drug for Type 2 Diabetes

Glenmark Pharma launches triple-combination drug for Type 2 Diabetes
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

United kingdomGlenmark pharmaceuticals onGlenmark pharmaceuticals

glenmark pharmaceuticals: Glenmark launches triple-drug combo for type 2 diabetes

Glenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, which combines Teneligliptin, Dapagliflozin, and Metformin, is priced at Rs 14 per tablet and aims to improve glycemic control in diabetic patients. The medication is expected to lower the daily cost of therapy by 30%, making it more affordable for patients.

Alok malikGlenmark pharmaGlenmark pharmaceuticals onGlenmark pharmaceuticalsPharma presidentBusiness headIndia formulations

Glenmark gets USFDA nod to market generic version of Otezla tablets

The company has received final approval from the US Food & Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.

United statesUs food drug administrationGlenmark pharmaceuticals onDrug administration

Latest News | Glenmark Pharma Shares Fall over 6 Pc After Nirma Deal

Get latest articles and stories on Latest News at LatestLY. Shares of Glenmark Pharmaceuticals on Friday fell over 6 per cent after the company said its board has approved divestment of 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore. Latest News | Glenmark Pharma Shares Fall over 6 Pc After Nirma Deal.

New delhiGlenn saldanhaGlenmark pharmaceuticals onNirma ltdGlenmark life sciencesGlenmark pharmaceuticalsCoast guard join searchGlenmark pharmaceuticals chairmanManaging director glenn saldanha

Glenmark board approves to sell 7% in Glenmark Life Sciences to Nirma for Rs 5,651 5 crore

NEW DELHI: Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,6.

Glenmark life sciences ltd to nirmaGlenmark life sciencesGlenmark pharmaceuticals onGlenmark pharmaceuticalsNirma ltdGlenmark life sciences ltdLife sciencesGlenmark lifeDrug maker

vimarsana © 2020. All Rights Reserved.